Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Study finds psilocybin treatment effective for affective disorders for up to one year

Staff Writer
Staff Writer 12 months ago
Updated 2022/02/16 at 12:07 AM
Share
SHARE

Researchers at Johns Hopkins have made new advancements in their research of the psychedelic compound psilocybin for the treatment of affective disorders.

According to their findings published in the Journal of Psychopharmacology, psilocybin may relieve symptoms associated with major depressive disorder for at least one year, when taken in conjunction with supportive psychotherapy.

More than 20 participants were recruited in the study, all of which had a long history of depression. The participants were mostly white, in mid-adulthood, and women.

“Participants were randomized to an immediate or delayed (8 weeks) treatment condition in which they received two doses of psilocybin with supportive psychotherapy,” the authors explained.


“Twenty-four participants completed both psilocybin sessions and were followed through 12 months following their second dose.”

The Johns Hopkins team unveiled that the anti-depressant effects from psilocybin were not only significant and immediate, but also had a long duration, making it an ideal new treatment for certain affective disorders.

“These findings demonstrate that the substantial antidepressant effects of psilocybin-assisted therapy may be durable at least through 12 months following acute intervention in some patients,” the authors determined.

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

Study establishes critical role in regulating excessive folding of gyri in brain

TAGGED: mental health, psilocybin, psychedelics
Staff Writer February 15, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article How exercising regularly may help boost vaccine antibodies
Next Article How gut fungi may influence neuroimmunity and social behavior

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
Clinical

New research finds Alzheimer’s risk factors affect males and females very differently

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?